Icosavax Inc (DELISTED) (ICVX:DL)
15.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 29, 16:00
Icosavax Shareholders Equity (Quarterly): 232.38M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 232.38M |
| June 30, 2023 | 247.72M |
| March 31, 2023 | 200.08M |
| December 31, 2022 | 218.16M |
| September 30, 2022 | 225.66M |
| June 30, 2022 | 242.43M |
| Date | Value |
|---|---|
| March 31, 2022 | 259.54M |
| December 31, 2021 | 278.22M |
| September 30, 2021 | 292.44M |
| June 30, 2021 | -39.30M |
| March 31, 2021 | -32.19M |
| December 31, 2020 | -26.70M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-39.30M
Minimum
Jun 2021
292.44M
Maximum
Sep 2021
174.87M
Average
229.02M
Median
Shareholders Equity (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 1.254B |
| Immunogen Inc (DELISTED) | 561.60M |
| AbbVie Inc | 10.36B |
| Assure Holdings Corp | -6.069M |
| Harpoon Therapeutics Inc (DELISTED) | 4.541M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 251.30M |
| Total Liabilities (Quarterly) | 18.92M |